Clarification sought from Lupin

25 May 2015 Evaluate

The Exchange has sought clarification from Lupin with respect to news article appearing on Financial Express on May 22, 2015 titled ‘Some drugs made by Lupin, DRL & Mylan lose EU approval.’

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2114.10 33.75 (1.62%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×